← Back
Data updated: Mar 29, 2026
EUGIA PHARMA
OncologyInfectious DiseaseCardiovascular
Generics
EUGIA PHARMA is a generic drug manufacturer focused on Oncology, Infectious Disease, Cardiovascular.
1994
Since
137
Drugs
-
Trials
1159
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
MEROPENEM 2026-02-17
Labeling
DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 35%
17 drugs
Infectious Disease 21%
10 drugs
Cardiovascular 17%
8 drugs
Dermatology 17%
8 drugs
Gastroenterology 10%
5 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Cardiovascular, Gastroenterology, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Active (81)
PAZOPANIB HYDROCHLORIDE PLERIXAFOR ALCAFTADINE PEMETREXED DISODIUM SUNITINIB MALATE LENALIDOMIDE TIROFIBAN HYDROCHLORIDE VASOPRESSIN POSACONAZOLE ICATIBANT ACETATE CARBOPROST TROMETHAMINE FULVESTRANT ERTAPENEM SODIUM CLOFARABINE DASATINIB BIVALIRUDIN EPTIFIBATIDE TIGECYCLINE NEOSTIGMINE METHYLSULFATE DAPTOMYCIN DEXMEDETOMIDINE HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE MOXIFLOXACIN HYDROCHLORIDE CAPECITABINE AZACITIDINE DECITABINE ESOMEPRAZOLE SODIUM PHENYLEPHRINE HYDROCHLORIDE LINEZOLID IBANDRONATE SODIUM CISATRACURIUM BESYLATE PRESERVATIVE FREE CISATRACURIUM BESYLATE LEVETIRACETAM IN SODIUM CHLORIDE DOXERCALCIFEROL TRANEXAMIC ACID PARICALCITOL FONDAPARINUX SODIUM BROMFENAC SODIUM ANASTROZOLE VORICONAZOLE DACTINOMYCIN PIPERACILLIN AND TAZOBACTAM ROCURONIUM BROMIDE BUDESONIDE LEVETIRACETAM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE IRINOTECAN HYDROCHLORIDE GRANISETRON HYDROCHLORIDE PANTOPRAZOLE SODIUM ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE CAFFEINE CITRATE AZITHROMYCIN DEXRAZOXANE HYDROCHLORIDE ESMOLOL HYDROCHLORIDE TAMOXIFEN CITRATE MESNA AMIODARONE HYDROCHLORIDE LEUPROLIDE ACETATE KETOROLAC TROMETHAMINE ACYCLOVIR SODIUM ATRACURIUM BESYLATE PRESERVATIVE FREE ETOMIDATE NICARDIPINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE VECURONIUM BROMIDE MITOMYCIN CROMOLYN SODIUM ACETYLCYSTEINE TIMOLOL MALEATE FLUPHENAZINE DECANOATE AMPHOTERICIN B VANCOMYCIN HYDROCHLORIDE NALOXONE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE TESTOSTERONE ENANTHATE METHYLPREDNISOLONE ACETATE TESTOSTERONE CYPIONATE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE SUCCINYLCHOLINE CHLORIDE METHOTREXATE SODIUM
Discontinued (47)
DILTIAZEM HYDROCHLORIDE MEROPENEM GLYCOPYRROLATE OLANZAPINE ZOLEDRONIC ACID CARBOPLATIN ARSENIC TRIOXIDE ISOSULFAN BLUE CHLORPROMAZINE HYDROCHLORIDE OXALIPLATIN FUROSEMIDE EPHEDRINE SULFATE ISOPROTERENOL HYDROCHLORIDE ACETAMINOPHEN SUMATRIPTAN SUCCINATE LETROZOLE TRIAMCINOLONE ACETONIDE EXEMESTANE LIDOCAINE HYDROCHLORIDE PROGESTERONE MILRINONE LACTATE IN DEXTROSE 5% ROPIVACAINE HYDROCHLORIDE DEXAMETHASONE SODIUM PHOSPHATE FOSAPREPITANT DIMEGLUMINE HYDRALAZINE HYDROCHLORIDE POLYMYXIN B SULFATE METHYLPREDNISOLONE SODIUM SUCCINATE TOBRAMYCIN SULFATE DOCETAXEL IMATINIB MESYLATE METHOCARBAMOL PROCHLORPERAZINE EDISYLATE MEDROXYPROGESTERONE ACETATE BUPIVACAINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE CYANOCOBALAMIN LIFITEGRAST LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER LEVOFLOXACIN BUSULFAN REGADENOSON ADENOSINE GENTAMICIN SULFATE BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE SODIUM NITROPRUSSIDE HYDROXYPROGESTERONE CAPROATE ATRACURIUM BESYLATE
Company Info
- First Approval
- 1994-04-26
- Latest
- 2026-02-03
- Applications
- 157